In Vitro Activity of a Novel Antifungal Compound, MYC-053, Against Clinically Significant Antifungal-Resistant Strains of Candida Glabrata, Candida Auris, Cryptococcus Neoformans, and Pneumocystis Spp.
Antimicrobial Agents and Chemotherapy - United States
